The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis

Dis Colon Rectum. 2012 Mar;55(3):330-6. doi: 10.1097/DCR.0b013e3182417358.

Abstract

Background: Pouchitis is the most common long-term complication after restorative total proctocolectomy and IPAA for ulcerative colitis.

Objective: We examined the incidence, clinical aspects, and long-term outcome of patients with idiopathic pouchitis.

Design: This study was a retrospective review of medical records.

Patients: Included in the study were 284 patients with ulcerative colitis who underwent a total proctocolectomy and IPAA.

Main outcome measures: We evaluated the cumulative risk and long-term outcome of pouchitis including the duration of disease, pattern of relapse, and responsiveness to antibiotic therapy.

Results: Sixty-four patients developed idiopathic pouchitis. The cumulative risk was 10.7% at 1 year, 17.2% at 2 years, 24.0% at 5 years, and 38.2% at 10 years. At their first pouchitis episode, 45 patients had acute pouchitis, 19 patients had chronic pouchitis, and all patients received antibiotic therapy with oral ciprofloxacin and/or metronidazole. The efficacy of the therapy was 96.6% initially. Forty-five patients had antibiotic-responsive pouchitis, 17 patients had antibiotic-dependent pouchitis, and 2 patients had antibiotic-refractory pouchitis at their first episode. Whereas 20 of 45 patients (44.4%) with initially acute pouchitis experienced 2 or more relapses, 16 of 19 patients (84.2%) with initially chronic pouchitis had 2 or more relapses. After taking into account the relapses, the number of patients with antibiotic-responsive pouchitis decreased from 45 to 40, the number with antibiotic-dependent pouchitis increased from 17 to 20, and the number with antibiotic-refractory pouchitis increased from 2 to 4. Among the 4 patients with antibiotic-refractory pouchitis, 3 patients had Clostridium difficile-associated pouchitis.

Limitations: This study was retrospective.

Conclusion: The patients with chronic pouchitis at the first episode tend to have a higher incidence of relapse. In some patients, the responsiveness to antibiotic therapy changes during follow-up. When patients with pouchitis do not respond to standard antibiotic therapy, then the occurrence of C difficile infection should be considered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Infective Agents / therapeutic use
  • Ciprofloxacin / therapeutic use
  • Colitis, Ulcerative / surgery*
  • Colonic Pouches / adverse effects*
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Metronidazole / therapeutic use
  • Pouchitis / diagnosis
  • Pouchitis / drug therapy
  • Pouchitis / etiology*
  • Proctocolectomy, Restorative / adverse effects*
  • Recurrence
  • Risk Factors

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Metronidazole
  • Ciprofloxacin